Sign in
4

Changes in Ownership

Vanda Pharmaceuticals Inc. Filed Acc 0001209191-22-034062

Director sold 6,441 shares at $9.90 ($63,779)

  • Director acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Watkins Thomas Director 2022-06-02 Option exercise +15,000 $4.15 $62,250 69,505 D
Watkins Thomas Director 2022-06-02 Sale −6,441 $9.90 $63,779 63,064 D
Derivatives
Watkins Thomas Director 2022-06-02 Option exercise · Stock Option (Right to Buy) −15,000 0 D
Open-market sales · 6,441 sh · avg $9.90 · $63,779
Loading xslF345X03/doc4.xml…